The article reports that the emergence of highly specific immuno-modulator drugs targeting toll-like receptors (TLR) will be the main topic of a conference in Salvador, Brazil. The conference will explore on the latest scientific progress in this field. The immune response profiles of TLR-targeting drugs are discussed.